Author

D. D'Andrea

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:behavioral assay· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Bhakta· 1 shared A. Carracedo· 1 shared A. Clear· 1 shared A. Orlova· 1 shared A. Q. Xu· 1 shared A. Tracz· 1 shared A. Varady· 1 shared A. Willbanks· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bhakta

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Gait speed is a biomarker of cancer-associated cachexia decline and recovery

I. Roy, B. Binder-Markey, D. Sychowski, A. Willbanks, T. Phipps, D. McAllister, A. Bhakta, E. Marquez, D. D'Andrea, C. Franz, R. Pichika, M. Dwinell, P. Jayabalan, R. L. Lieber

This paper identifies gait speed as a more reliable biomarker of cancer-associated cachexia decline and recovery compared to grip strength, using both animal models and human patient data.

bioRxiv · Nov 13, 2023 · PreprintCancer Biology

STAT3 restricts prostate cancer metastasis and antiandrogen resistance by controlling LKB1/CREB signaling pathway

J. Pencik, C. Philippe, M. Schlederer, M. Pecoraro, S. Grund-Groeschke, W. J. Li, A. Tracz, I. Heidegger, S. Lagger, K. Trachtova, M. Oberhuber, E. Heitzer, O. Osman, H. A. Neubauer, B. Wingelhofer, , C. McKinney

This study identifies STAT3's role in restricting prostate cancer metastasis and antiandrogen resistance by regulating the LKB1/CREB signaling pathway in mouse models and human patients.

bioRxiv · Aug 25, 2022 · PreprintCancer Biology

Co-activation of NF-κB and MYC renders cancer cells addicted to IL6 for survival and phenotypic stability

R. Barbosa, A. Q. Xu, D. D'Andrea, F. Copley, H. Patel, P. Chakravarty, A. Clear, M. Calaminici, M. Janz, B. Zhang, M. Schmidt-Supprian, J. Wang, J. Gribben, R. Tooze, J. Fitzgibbon, , D. P. Calado

This paper shows that co-activation of NF-κB and MYC in cancer cells makes them dependent on IL6 for survival and leads to a poorly-differentiated state similar to human plasmablastic lymphoma and t(8;14)[MYC-IGH] multiple myeloma.

bioRxiv · Apr 12, 2020 · PreprintCancer Biology